(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 30 Oct 2023 | 30 Jul 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Total current assets | ||||
Long term investments | ||||
Property, plant & equipment | ||||
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | ||||
Current liabilities | ||||
Accounts payable | ||||
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | ||||
Long term debt | ||||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | ||||
Shareholders' equity | ||||
Retained earnings | ||||
Other shareholder equity | ||||
Total shareholder equity |
(in millions $) | 31 Jan 2025 | 31 Jan 2024 | 1 May 2023 | 1 May 2022 |
---|---|---|---|---|
Current assets | ||||
Cash | $34.67 | |||
Short term investments | ||||
Net receivables | $22.62 | $25.82 | ||
Inventory | ||||
Total current assets | $44.7 | $61.02 | ||
Long term investments | $1346.94 | |||
Property, plant & equipment | ||||
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $1336.05 | $1408.14 | ||
Current liabilities | ||||
Accounts payable | $46.8 | $33.54 | ||
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $261.82 | $49.05 | ||
Long term debt | $281.07 | $218.35 | ||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $542.89 | $460.99 | ||
Shareholders' equity | ||||
Retained earnings | -$417.03 | -$111.03 | ||
Other shareholder equity | ||||
Total shareholder equity | $947.16 |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 30 Oct 2023 | 30 Jul 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | ||||
Cost of revenue | ||||
Gross Profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | ||||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | ||||
Interest expense | ||||
Net income | ||||
Net income | ||||
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 1 May 2023 | 1 May 2022 | 30 Mar 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $262.27 | $199.3 | $127.35 | |
Cost of revenue | ||||
Gross Profit | $165.95 | $123.7 | $127.35 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $34.65 | |||
Total operating expenses | $12.41 | $3.9 | $34.65 | |
Operating income | $92.69 | |||
Income from continuing operations | ||||
EBIT | $92.69 | |||
Income tax expense | ||||
Interest expense | -$324.83 | $6.09 | -$16.28 | |
Net income | ||||
Net income | -$171.29 | $125.88 | $289.93 | |
Income (for common shares) | $289.93 |
(in millions $) | 1 May 2023 | 30 Oct 2022 | 29 Jun 2022 | 1 May 2022 |
---|---|---|---|---|
Net income | -$92.72 | |||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$35.78 | |||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | ||||
Financing activities | ||||
Dividends paid | -$122.53 | -$58.58 | -$29.29 | -$85.6 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $78.63 | $82.87 | $41.44 | $329.3 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$12.93 | $11.32 | $5.66 | -$56.19 |
(in millions $) | 1 May 2023 | 1 May 2022 | 30 Mar 2021 | 30 Mar 2020 |
---|---|---|---|---|
Net income | $289.93 | -$291.13 | ||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$7.94 | -$271.22 | ||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | ||||
Financing activities | ||||
Dividends paid | -$122.53 | -$85.6 | -$75.09 | -$83.99 |
Sale and purchase of stock | ||||
Net borrowings | $59.78 | -$2.49 | ||
Total cash flows from financing | $78.63 | $329.3 | $87.14 | $261.41 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$12.93 | -$56.19 | $79.2 | -$9.81 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |